TY - JOUR
T1 - Social participation is reduced in type 3 Von Willebrand disease patients and in patients with a severe bleeding phenotype
AU - Kempers, Eva K.
AU - van Kwawegen, Calvin B.
AU - for the WiN study group
AU - de Meris, Joke
AU - Schols, Saskia E.M.
AU - van Galen, Karin P.M.
AU - Meijer, Karina
AU - Cnossen, Marjon H.
AU - van der Bom, Johanna G.
AU - Fijnvandraat, Karin
AU - Eikenboom, Jeroen
AU - Atiq, Ferdows
AU - Leebeek, Frank W.G.
N1 - ACKNOWLEDGMENTS
This study was supported by research funding from the Dutch Haemophilia Foundation (Stichting Haemophilia) and CSL Behring (unrestricted grant).
Publisher Copyright:
© 2021 The Authors. Haemophilia published by John Wiley & Sons Ltd.
PY - 2022/3
Y1 - 2022/3
N2 - Introduction: The negative impact of haemophilia on social participation is well established in previous studies, however, the impact of Von Willebrand disease (VWD) on social participation has not been studied. Aim: To compare the social participation of a large cohort of VWD patients in the Netherlands with the general Dutch population. In addition, to identify factors associated with social participation in VWD. Methods: Patients participating in the “Willebrand in the Netherlands” study completed an extensive questionnaire on educational level, absenteeism from school or work, and occupational disabilities. Results: Seven-hundred and eighty-eight VWD patients were included (mean age 38.9 years, 59.5% females), of whom 136 children < 16 years. Adult patients with type 3 VWD more often had a low educational level (52.9%) compared to type 1 (40.2%), type 2 VWD (36.8%) and the general population (36.4%) (p =.005). Moreover, in patients aged ≥16 years the days lost from school and/or work in the year prior to study inclusion differed significantly between the VWD types (p =.011). Using negative binomial regression analysis, the occurrence of bleeding episodes requiring treatment in the year preceding study inclusion was significantly associated with the number of days lost from school and/or work among patients aged ≥16 years. Multivariable logistic regression analysis showed that a higher total bleeding score, older age and presence of at least one comorbidity were significantly associated with occupational disability in patients aged ≥16 years. Conclusion: Our study shows that social participation was lower in type 3 VWD and VWD patients with a more severe bleeding phenotype.
AB - Introduction: The negative impact of haemophilia on social participation is well established in previous studies, however, the impact of Von Willebrand disease (VWD) on social participation has not been studied. Aim: To compare the social participation of a large cohort of VWD patients in the Netherlands with the general Dutch population. In addition, to identify factors associated with social participation in VWD. Methods: Patients participating in the “Willebrand in the Netherlands” study completed an extensive questionnaire on educational level, absenteeism from school or work, and occupational disabilities. Results: Seven-hundred and eighty-eight VWD patients were included (mean age 38.9 years, 59.5% females), of whom 136 children < 16 years. Adult patients with type 3 VWD more often had a low educational level (52.9%) compared to type 1 (40.2%), type 2 VWD (36.8%) and the general population (36.4%) (p =.005). Moreover, in patients aged ≥16 years the days lost from school and/or work in the year prior to study inclusion differed significantly between the VWD types (p =.011). Using negative binomial regression analysis, the occurrence of bleeding episodes requiring treatment in the year preceding study inclusion was significantly associated with the number of days lost from school and/or work among patients aged ≥16 years. Multivariable logistic regression analysis showed that a higher total bleeding score, older age and presence of at least one comorbidity were significantly associated with occupational disability in patients aged ≥16 years. Conclusion: Our study shows that social participation was lower in type 3 VWD and VWD patients with a more severe bleeding phenotype.
UR - http://www.scopus.com/inward/record.url?scp=85122077346&partnerID=8YFLogxK
U2 - 10.1111/hae.14475
DO - 10.1111/hae.14475
M3 - Article
C2 - 34964530
AN - SCOPUS:85122077346
SN - 1351-8216
VL - 28
SP - 278
EP - 285
JO - Haemophilia
JF - Haemophilia
IS - 2
ER -